
Comparison of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi-parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer
Author(s) -
Mengxia Chen,
Qing Zhang,
Chengwei Zhang,
Yihua Zhou,
Xiaozhi Zhao,
Yao Fu,
Jie Gao,
Bing Zhang,
Feng Wang,
Xuefeng Qiu,
Guo H
Publication year - 2020
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2020.03.06
Subject(s) - prostate cancer , magnetic resonance imaging , positron emission tomography , glutamate carboxypeptidase ii , medicine , computed tomography , tomography , positron emission tomography computed tomography , nuclear medicine , radiology , computed tomography laser mammography , preclinical imaging , cancer , microbiology and biotechnology , biology , in vivo
To compare the diagnostic performance of 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography ( 68 Ga-PSMA PET/CT) with multi-parametric magnetic resonance imaging (mpMRI) on extracapsular extension (ECE) and seminal vesicle invasion (SVI) in primary prostate cancer and its impact on therapeutic decisions.